A new approach to in-vitro dissolution measurement and GI modelling
Wednesday, 25 May 2011
The Marriott Hollins Hall Hotel & Country Club, Hollins Hill, Baildon, Shipley, Bradford. BD17 7QW United Kingdom.
With the drive to reduce the timescales and cost of developing drug molecules through to a finished dosage form, a detailed understanding of the important physico-chemical properties of the molecule needs to be determined early in development. This can now be realised with the recently introduced two dimensional, orthogonal, UV imaging laminar flow-through device, the SDI300, which offers incredibly rich data. By relocating measurements to the solid-liquid interface using media at physiological flow rates across a few mg of sample, the SDI300 opens tremendous new insights. Exciting new areas related to GI modelling and bioavailability also become available for research. This symposium will highlight the applications and benefits of UV imaging for flow through dissolution.
Presenters include: Dr. Stephen Wren (AstraZeneca), Dr. Nikoletta Fotaki (University of Bath), Dr. Deirdre D’Arcy (Trinity College Dublin), Profs. Jukka Rantanen & Jesper Østergaard (University of Copenhagen) and Prof. Robert Forbes (University of Bradford).
NOTES:
- Paraytec Ltd is a scientific instrument company based in York, UK, designing, developing and manufacturing innovative detectors. Paraytec was established in January 2005 as a spin-out from the Chemistry Department at the University of York, UK.
- The Biopharmaceutical Formulation Group (University of Bradford), is a speciality research group providing state of the art analytical and development solutions to the biopharmaceutical industry.
For further information please contact Paraytec Ltd. on +44-1904-436620 or email [email protected]